CD8A and neoplasm: Pretreatment of tumour cells with IFNγ slightly enhanced the activation of CD8+ T cells by Ma-Mel-36_bulk and Ma-Mel-36_sens cells, whereas the T-cell-stimulatory capacity of Ma-Mel-36_res cells was not affected.